L. Kunze

发表

Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution

N. Albert, M. Riemenschneider, J. Herms, 2023, bioRxiv.

A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models

Nicholas E. Propson, K. Scearce-Levie, Steve Lianoglou, 2023, Nature Neuroscience.

Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

Julie A. Harris, Jennifer D. Whitesell, K. Scearce-Levie, 2022, Molecular neurodegeneration.

Longitudinal Studies on Alzheimer Disease Mouse Models with Multiple Tracer PET/CT: Application of Reduction and Refinement Principles in Daily Practice to Safeguard Animal Welfare during Progressive Aging

M. Brendel, S. Lindner, R. Oos, 2023, Animals : an open access journal from MDPI.

Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution

N. Albert, M. Riemenschneider, J. Herms, 2023, bioRxiv.

Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice

J. Herms, M. Brendel, F. Eckenweber, 2023, International journal of molecular sciences.

18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model

N. Albert, K. Wind, M. Riemenschneider, 2022, Frontiers in Medicine.

Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging

A. Zwergal, K. Wind, J. Herms, 2023, NeuroImage: Clinical.

Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution

M. Riemenschneider, M. Brendel, S. Lindner, 2023, Science advances.